This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Revascularization  • Bacterial Infections  • Cardiovascular System  • Cardiovascular Disease/ Myocardial Infarction  • Cardiovascular Intervention  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Eric V. Granowitz, MD; David L. Longworth, MD

JAMA. 2003;289:1991-1993.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Before the advent of antibiotics, infective endocarditis was almost always fatal. With the introduction of penicillin in 1941, endocarditis became a treatable disease. However, many patients still died, predominantly of congestive heart failure resulting from valve destruction.¹

In 1960, Kay et al² successfully performed tricuspid valve debridement and closure of a ventricular septal defect in a patient with active Candida endocarditis. For patients with endocarditis, cardiac valve replacement surgery was initially performed to replace damaged valves only after the successful eradication of infection. In 1965, Wallace et al³ described a patient with active endocarditis who failed to respond to antibiotics alone but was cured by the combination of valve replacement and antibiotics.

During the next 2 decades, reports from observational studies argued in favor of the effectiveness of valve replacement in patients with active endocarditis complicated by congestive heart failure or uncontrolled . . . [Full Text of this Article]

Author Affiliations: Department of Medicine, Baystate Medical Center and Tufts University School of Medicine, Springfield, Mass.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Complicated Left-Sided Native Valve Endocarditis in Adults: Risk Classification for Mortality
Rodrigo Hasbun, Holenarasipur R. Vikram, Lydia A. Barakat, Joan Buenconsejo, and Vincent J. Quagliarello
JAMA. 2003;289(15):1933-1940.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Development and validation of a time-dependent risk model for predicting mortality in infective endocarditis
Sy et al.
Eur Heart J 2009;0:ehp085v1-ehp085.
ABSTRACT | FULL TEXT  

Risk-Stratifying Patients with Infective Endocarditis
Journal Watch Cardiology 2003;2003:3-3.
FULL TEXT  

Estimating Endocarditis Outcomes
JWatch Infect. Diseases 2003;2003:2-2.
FULL TEXT